Drugs / CD147- CAR T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05013372 | Jan 2023 → Jan 2024 | T-cell non-Hodgkin lymphoma | Peking University People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD147- CAR T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05013372 ↗ |
| Action | Deplete | “CAR T cells targeting CD147 antigen can continuously eliminate Jurkat T-cell lymphoma in mice” NCT05013372 ↗ |
| Modality | Cell therapy | “CAR T cells” NCT05013372 ↗ |